MONCEF JENDOUBI, Founder, President & Acting CEO



Dr. Jendoubi holds a MS in Genetics, a MS in Biochemistry, a Ph.D. in Molecular Biology, a “Doctorat D’Etat Es Sciences” in Immunology, a special Diploma in bacteriology from the University of Paris, and was trained at the Pasteur Institute, where he held the position of Associate Professor. In 1987, Dr. Jendoubi joined the National Institutes of Health as Visiting Professor, and became Chief of the Genetics and Molecular Immunology Section in 1990.
During his career at the NIH he developed research aimed at understanding cell-cell communication pathways using genetically engineered mice and molecular genetics. He is the author of dozens of publications and patents. Throughout his scientific and entrepreneurial career, he founded and co-founded several successful biotech companies in the diagnostic and therapeutic field. He founded and managed Milagen Inc., from its inception to a fully integrated diagnostic company.
Dr. Jendoubi has also co-founded Abnova Corporation in Taipei, Taiwan in March 2001, Phenotype Pharmaceuticals in 2004, and ServaCare in 2012,in Mexico City, Mexico. Dr. Jendoubi is currently an active member of the American Society of Clinical Oncology (ASCO), the American Association of Clinical Chemistry (AACC), and Associate Member of the Early Detection Research Network of the National Cancer Institute (EDRN-NCI-NIH).